Tarsus Pharmaceuticals, Inc. TARS Deferred Tax Assets, Charitable Contribution Carryforwards
Deferred Tax Assets, Charitable Contribution Carryforwards at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s deferred tax assets, charitable contribution carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s deferred tax assets, charitable contribution carryforwards?
- Tarsus Pharmaceuticals, Inc. (TARS) reported deferred tax assets, charitable contribution carryforwards of $27.69M in Q4 2025.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s deferred tax assets, charitable contribution carryforwards?
- Over 2 years (2023 to 2025), Tarsus Pharmaceuticals, Inc.'s deferred tax assets, charitable contribution carryforwards has grown at a 351.2% compound annual growth rate (CAGR), from $1.36M to $27.69M.
- What does deferred tax assets, charitable contribution carryforwards mean?
- This represents the value of charitable contributions that exceed current tax deduction limits and are carried forward to offset future taxable income. It reflects the company's philanthropic activity and the resulting tax benefits that remain available for future use. This metric helps investors understand the company's tax planning strategy and potential future tax savings.